William Blair on Biogen (BIIB): 'we see potential to add $1.54 billion in sales' through APLS deal
Tweet Send to a Friend
William Blair analyst Myles R. Minter reiterated an Outperform rating on Biogen (NASDAQ: BIIB)The analyst commented, "There will be debate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
